Axcella is Biotechnology in United States that focus on Axcella Health Inc business. Founded in 2009. They cover business area such as Axcella Health Inc, complex disease, health, endogenous metabolic modulator, EMM, composition, its product candidate, multiple emm, distinct combination, ratio, multiple biological pathway, therapeutic candidate, risk, recurrent overt hepatic encephalopathy, non-alcoholic steatohepatitis.
2009
( 15 years old in 2024 )
Axcella Health Inc
-
840 Memorial Drive
Entrance on Blackstone Street, Third Floor
Cambridge, MA 02139
United States
Private
Axcella Health Inccomplex diseasehealthendogenous metabolic modulatorEMMcompositionits product candidatemultiple emmdistinct combinationratiomultiple biological pathwaytherapeutic candidateriskrecurrent overt hepatic encephalopathynon-alcoholic steatohepatitis
* We use standard office opening hours in near Axcella's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Axcella is Biotechnology business from United States that founded in 2009 (15 years old in 2024), Axcella business is focusing on Axcella Health Inc.
Axcella headquarter office and corporate office address is located in 840 Memorial Drive Entrance on Blackstone Street, Third Floor Cambridge, MA 02139 United States.
Axcella was founded in United States.
In 2024, Axcella is currently focus on Axcella Health Inc sector.
Above is snippet of Google Trends for "Axcella Health Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Axcella, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
